Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Former St. Jude exec Craig seeks Minn. Congressional seat
Former St. Jude Medical HR executive Angie Craig is looking to take a seat in Minnesota’s 2nd Congressional district for Democrats this year in a closely watched race.
Craig is facing off against libertarian talk-show host Jason Lewis (R) for the seat held by Rep. John Kline (R), who’s retiring after 14 years on Capitol Hill. Read more
4. High-capacity nanoparticle holds potential for targeted cancer therapies
Chemists from the Mass. Institute of Technology developed a nanoparticle that they can pack with 3 or more drugs to create custom combination therapies for cancer, according to a study published this week in the Journal of the American Chemical Society.
The team also revealed that cisplatin, a powerful anti-cancer drug, doesn’t work using the same DNA-damaging mechanism when delivered via nanoparticle compared to traditional methods. Read more
3. Hologram tech allows surgeons to manipulate images within sterile field
NZ Technologies Tipso, a Vancouver-based technology firm, developed an interactive hologram device to assist surgeons and radiologists at British Columbia’s Surrey Memorial Hospital.
The system, called Tipso – or “touchless interaction with PACs in sterile operation” – is designed to project a holographic menu with all the controls for the picture archiving & communication system directly onto the patient’s bed drape, within the sterile field. Read more
2. Diabetes: Medtronic touts JAMA study of closed-loop artificial pancreas
Medtronic said data from a study of its closed-loop hybrid artificial pancreas, published in the Journal of the American Medical Assn., showed that the system is safe and effectively maintained blood glucose levels within range in Type I diabetes patients age 14 and older.
Results from the 3-month, 124-patient trial, also presented this week at the annual meeting of the European Assn. for the Study of Diabetes in Munich, had safety endpoints of the incidence of severe hypoglycemia and diabetic ketoacidosis, serious adverse events and device-related serious and unanticipated adverse events. Data from the study was 1st presented in June at the American Diabetes Assn.’s annual meeting. Read more
1. Zimmer Biomet picks up imaging company Clinical Graphics
Zimmer Biomet said today that it picked up novel imaging company Clinical Graphics for an undisclosed amount.
Warsaw, Ind.-based Clinical Graphics produces 3D range-of-motion simulation technology designed to aid in making treatment decisions for hip conditions which require early interventions, including femoracetabular impingement and dysplasia. Read more
